IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 171 filers reported holding IVERIC BIO INC in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $36,606,383 | -50.1% | 1,504,578 | -56.1% | 0.82% | -46.2% |
| Q4 2022 | $73,326,081 | -22.1% | 3,424,852 | -34.7% | 1.52% | -19.0% |
| Q3 2022 | $94,079,000 | +87.6% | 5,244,098 | +0.6% | 1.87% | +81.0% |
| Q2 2022 | $50,159,000 | -39.1% | 5,214,000 | +6.6% | 1.04% | -43.8% |
| Q1 2022 | $82,332,000 | +3.4% | 4,891,996 | +2.7% | 1.84% | +10.2% |
| Q4 2021 | $79,606,000 | +0.8% | 4,761,138 | -2.1% | 1.67% | +8.3% |
| Q3 2021 | $78,987,000 | +117.0% | 4,863,725 | -15.7% | 1.54% | +138.7% |
| Q2 2021 | $36,392,000 | +2.1% | 5,767,409 | 0.0% | 0.65% | -13.8% |
| Q1 2021 | $35,643,000 | -10.6% | 5,767,409 | 0.0% | 0.75% | -4.9% |
| Q4 2020 | $39,853,000 | +22.5% | 5,767,409 | 0.0% | 0.79% | -0.5% |
| Q3 2020 | $32,528,000 | +10.6% | 5,767,409 | 0.0% | 0.79% | -7.6% |
| Q2 2020 | $29,414,000 | +277.1% | 5,767,409 | +154.4% | 0.86% | +245.6% |
| Q1 2020 | $7,800,000 | -9.1% | 2,267,409 | +126.7% | 0.25% | -9.5% |
| Q4 2019 | $8,580,000 | – | 1,000,000 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |